Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BLEOMYCIN vs BLINATUMOMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BLEOMYCIN vs BLINATUMOMAB: Safety Overview

Metric BLEOMYCIN BLINATUMOMAB
Total FAERS Reports 6,908 9,161
Deaths Reported 1,529 1,664
Death Rate 22.1% 18.2%
Hospitalizations 2,214 2,427
Average Patient Age 39.5 yrs 39.7 yrs
% Female Patients 43.5% 46.7%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Hospira, Inc. Amgen, Inc
Route INTRAMUSCULAR N/A
Marketing Status Discontinued Prescription